Correction of psychological and neurological signs of alcohol hangover in rats with acetylcysteine


如何引用文章

全文:

详细

The development of medications to treat alcohol hangover is important for a large number of people, especially those, who perform responsible and dangerous types of work. The severity of the hangover syndrome is determined by the toxic effect of acetaldehyde and its metabolic rate, which decreases with the depletion of glutathione, worsening and prolonging the hangover.The aim of the article is to provide an experimental basis for use of acetylcysteine as a precursor of glutathione in treatment of psychological, neurological and cognitive symptoms of ethanol hangover.Materials and methods. The study was performed in male Wistar rats. The ethanol hangover was modeled via an acute ethanol injection (i.p., 3 g/kg). After awakening, the animals were divided into 2 groups, receiving acetylcysteine (p.o., 1 mg/ kg) or saline. The intact group of the animals received saline only. Before and after acetylcysteine or saline administration, the animals were assessed according to Combs and D'Alecy scale. The adhesive test, the open field test, the passive avoidance test and Morris water maze test were also performed twice. The liver glutathione level was assessed in sacrificed animals. Results. The control group animals showed signs of neurological deficits and cognitive impairment, including a decreased locomotion, motor deficits and a memory decline. The rats administered with acetylcysteine after the ethanol intoxication, had a less severe impairment associated with an improved performance in the adhesive test, Morris water maze test and the passive avoidance test, and demonstrated an increased locomotion in the open field test. The liver glutathione content in the animals treated with acetylcysteine, was comparable to the glutathione content in the liver of the animals not exposed to the ethanol intoxication.Conclusion. Against the background of an acute ethanol intoxication, an oral administration of acetylcysteine in the rats, promoted an increase in liver glutathione levels and led to a decrease in severity of neurological and cognitive deficits in the animals.

作者简介

D. Kurkin

Volgograd State Medical University

Email: strannik986@mail.ru

E. Morkovin

Volgograd State Medical University

Email: e.i.morkovin@gmail.com

N. Osadchenko

Volgograd State Medical University

Email: n.a.osadchenko@gmail.com

L. Knyshova

Volgograd State Medical University

Email: knyshova-liliya@inbox.ru

D. Bakulin

Volgograd State Medical University

Email: mbfdoc@gmail.com

E. Abrosimova

Volgograd State Medical University

Email: abrosimiva.volgmed@gmail.com

Yu. Gorbunova

Volgograd State Medical University

Email: yvgorbunova@yandex.ru

I. Tyurenkov

Volgograd State Medical University

Email: fibfuv@mail.ru

参考

  1. Mackus M., Adams S., Barzilay A., Benson S., Blau L., Iversen J., Johnson S.J., Keshavarzian A., Scholey A., Smith G.S., Trela C., Vatsalya V., Verster J.C. Proceeding of the 8th Alcohol Hangover Research Group Meeting. Curr Drug Abuse Rev. 2016. V. 9, N 2. P. 106-112. doi: 10.2174/1874473709666161229121527.
  2. Penning R., McKinney A., Verster J.C. Alcohol hangover symptoms and their contribution to the overall hangover severity. Alcohol Alcohol. 2012. V. 47, N 3. P. 248-252. doi: 10.1093/alcalc/ags029.
  3. Devenney L.E., Coyle K.B., Verster J.C. Memory and attention during an alcohol hangover. Hum Psychopharmacol. 2019. V. 34, N 4. P. e2701. doi: 10.1002/hup.2701.
  4. Grange J.A., Stephens R., Jones K., Owen L. The effect of alcohol hangover on choice response time. J Psychopharmacol. 2016 V. 30, N 7. P. 654-661. doi: 10.1177/0269881116645299.
  5. Verster J.C., Bervoets A.C., de Klerk S., Vreman R.A., Olivier B., Roth T., Brookhuis K.A. Effects of alcohol hangover on simulated highway driving performance. Psychopharmacology (Berl). 2014 V. 231, N 15. P. 2999-3008. doi: 10.1007/s00213-014-3474-3479.
  6. Sarkola T., Eriksson C.J. Testosterone increases in men after a low dose of alcohol. Alcohol Clin Exp Res. 2003. V. 27, N 4. P. 682-685. doi: 10.1097/01.alc.0000060526.43976.68
  7. Alomary A.A., Vallee M., O'Dell L.E., Koob G.F., Purdy R.H., Fitzgerald R.L. Acutely administered ethanol participates in testosterone synthesis and increases testosterone in rat brain. Alcohol Clin Exp Res. 2003. V. 27, N 1. P. 38-43. doi: 10.1097/01.alc.0000047304.28550.4f
  8. Penning R., McKinney A., Bus L.D., Olivier B., Slot K., Verster J.C. Measurement of alcohol hangover severity: development of the Alcohol Hangover Severity Scale (AHSS). Psychopharmacology (Berl). 2013. V. 225, N 4. P. 803-810. doi: 10.1007/s00213-012-2866-y.
  9. Th0rrisen M.M., Bonsaksen T., Hashemi N., Kjeken I., van Mechelen W., Aas R.W. Association between alcohol consumption and impaired work performance (presenteeism): a systematic review. BMJ Open. 2019. V. 9, N 7. P. e029184. doi: 10.1136/bmjopen-2019-029184.
  10. Swift R., Davidson D. Alcohol hangover: mechanisms and mediators. Alcohol Health Res World. 1998. V. 22, N 1. P. 54-60.
  11. Labhart F., Livingston M., Engels R., Kuntsche E. After how many drinks does someone experience acute consequences-determining thresholds for binge drinking based on two event-level studies. Addiction. 2018. V. 113, N 12. P. 2235-2244. doi: 10.1111/add.14370.
  12. Lam T., Liang W., Chikritzhs T., Allsop S. Alcohol and other drug use at school leavers' celebrations. J Public Health (Oxf). 2014. V. 36, N 3. P. 408-416. doi: 10.1093/pubmed/fdt087.
  13. Verster J.C., Penning R. Treatment and prevention of alcohol hangover. Curr Drug Abuse Rev. 2010. V. 3, N 2. P. 103-109. doi: 10.2174/1874473711003020103
  14. Green J.L. Heard K.J., Reynolds K.M., Albert D. Oral and intravenous acetylcysteine for treatment of acetaminophen toxicity: a systematic review and metaanalysis. West J Emerg Med. 2013. V. 14, N 3. P. 218-226. doi: 10.5811/westjem.2012.4.6885.
  15. Морковин Е.И., Куркин Д.В., Тюренков И.Н. Оценка психоневрологического дефицита у грызунов: основные методы. Журнал высшей нервной деятельности им. И. П. Павлова. 2018. V. 68, N 1. P. 3-15. doi: 10.7868/s004446771801001x
  16. Combs D.J., D'Alecy L.G. Motor performance in rats exposed to severe forebrain ischemia: effect of fasting and 1,3-butanediol. Stroke. 1987. V. 18, N 2. P. 503-511.
  17. Bouet V., Boulouard M., Toutain J., Divoux D., Bernaudin M., Schumann-Bard P., Freret T. The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice. Nat Protoc. 2009. V. 4, N 10. P. 1560-1564. doi: 10.1038/nprot.2009.125
  18. Руководство по проведению доклинических исследований лекарственных средств: под ред. А.Н. Миронова. Ч. 1. М.: ГрифиК, 2012. 944 с.
  19. Vorhees C.V., Williams M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006. V. 1, N 2. P. 848-858. doi: 10.1038/nprot.2006.116.
  20. Shaik I.H., Mehvar R. Rapid determination of reduced and oxidized glutathione levels using a new thiol-masking reagent and the enzymatic recycling method: Application to the rat liver and bile samples. Anal Bioanal Chem. 2006. V. 385, N 1. P. 105-113. doi: 10.1007/s00216-006-0375-8.
  21. Cederbaum A.I. Alcohol metabolism. Clin Liver Dis. 2012. V. 16, N 4. P. 667-685. doi: 10.1016/j.cld.2012.08.002.
  22. Rushworth G.F., Megson I.L. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. PharmacolTher. 2014. V. 141, N 2. P. 150-159. doi: 10.1016/j.pharmthera.2013.09.006.
  23. Green J.L., Heard K.J., Reynolds K.M., Albert D. Oral and intravenous acetylcysteine for treatment of acetaminophen toxicity: a systematic review and meta-analysis. West J Emerg Med. 2013. V. 14, N 3. P. 218-226. doi: 10.5811/westjem.2012.4.6885.
  24. Aldini G., Altomare A., Baron G., Vistoli G., Carini M., Borsani L., Sergio F. N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why. Free Radic Res. 2018. V. 52, N 7. P. 751-762. doi: 10.1080/10715762.2018.1468564.
  25. Oja S.S., Janaky R., Varga V., Saransaari P. Modulation of glutamate receptor functions by glutathione. Neurochem Int. 2000. V. 37, N 2-3. P. 299-306. doi: 10.1016/s0197-0186(00)00031-0
  26. Chen H.H., Stoker A., Markou A. The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice. Psychopharmacology (Berl). 2010. V. 209, N 4. P. 343-350. doi: 10.1007/s00213-010-1802-2.
  27. Paterson R.L., Galley H.F., Webster N.R. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med. 2003. V. 31, N 11. P. 2574-2578. doi: 10.1097/01.ccm.0000089945.69588.18
  28. Kupchik Y.M., Moussawi K., Tang X.C., Wang X., Kalivas B.C., Kolokithas R., Ogburn K.B., Kalivas P.W. The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine. Biol Psychiatry. 2012. V. 71, N 11. P. 978-986. doi: 10.1016/j.biopsych.2011.10.024.

版权所有 © Kurkin D.V., Morkovin E.I., Osadchenko N.A., Knyshova L.P., Bakulin D.A., Abrosimova E.E., Gorbunova Y.V., Tyurenkov I.N., 2019

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可
 
##common.cookie##